- Public Comps
- Organo
Organo Valuation Multiples
Discover Organo's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Fujian Funeng, Empower, Algonquin Power & Utilities, Global Power Synergy and more.
Organo Overview
About Organo
Organo Corp is a Japan-based company mainly engaged in the water treatment engineering business. The company operates in two business divisions namely water treatment engineering and functional product. Its water treatment engineering business includes manufacturing, delivery and maintenance of pure water systems, ultra-pure water systems and wastewater treatment systems for industries, condensate de mineralizers for power stations, waterworks and sewage treatment systems for the public sector. The functional product business encompasses the sale of standardized water treatment equipment, water treatment chemicals, and food processing materials.
Founded
1941
HQ

Employees
2.2K
Website
Financials (LTM)
EV
$4.1B
Valuation Multiples
Start free trialOrgano Financials
Organo reported last 12-month revenue of $1.2B and EBITDA of $258M.
In the same LTM period, Organo generated $417M in gross profit, $258M in EBITDA, and $183M in net income.
Revenue (LTM)
Organo P&L
In the most recent fiscal year, Organo reported revenue of $1.1B and EBITDA of $251M.
Organo is profitable as of last fiscal year, with gross margin of 36%, EBITDA margin of 22%, and net margin of 16%.
Financial data powered by Morningstar, Inc.
Organo Stock Performance
Organo has current market cap of $4.4B, and enterprise value of $4.1B.
Market Cap Evolution
Organo's stock price is $96.16.
Organo share price decreased by 4.5% in the last 30 days, and increased by 61.9% in the last year.
Organo has an EPS (earnings per share) of $3.91.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.1B | $4.4B | -1.4% | -4.5% | -2.4% | 61.9% | $3.91 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOrgano Valuation Multiples
Organo trades at 3.5x EV/Revenue multiple, and 15.9x EV/EBITDA.
EV / Revenue (LTM)
Organo Financial Valuation Multiples
As of July 17, 2026, Organo has market cap of $4.4B and EV of $4.1B.
Organo has a P/E ratio of 24.1x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Organo Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Organo Margins & Growth Rates
Organo grew revenue by 11% and EBITDA by 10% in the last fiscal year.
In the most recent fiscal year, Organo reported gross margin of 36%, EBITDA margin of 22%, and net margin of 16%.
Organo Margins
Organo Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Organo Operational KPIs
Organo's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Organo's Rule of 40 is 35% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Organo's Rule of X is 54% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Organo Competitors
Organo competitors include Fujian Funeng, Empower, Algonquin Power & Utilities, Global Power Synergy, China Resources Gas, NorthWestern Energy, TAQA Morocco, TAURON, China Power and Riyadh Cables.
Most Organo public comparables operate across Utilities, Waste & Environmental Services and ClimateTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.0x | 3.0x | 6.2x | 6.8x | |||
| 5.5x | 5.3x | 11.2x | 11.3x | |||
| 4.6x | 4.4x | 11.2x | 10.8x | |||
| 2.6x | 2.8x | 11.1x | 11.9x | |||
| 0.5x | 0.5x | 4.4x | 4.8x | |||
| 4.9x | 4.7x | 13.1x | 12.3x | |||
| 4.5x | 4.4x | 14.4x | 14.2x | |||
| 0.8x | 0.9x | 3.8x | 4.1x | |||
This data is available for Pro users. Sign up to see all Organo competitors and their valuation data. Start Free Trial | ||||||
Investments by Organo
Organo has invested in 1 company to date.
Latest investment by Organo was on November 18th 2024. Organo invested in LIGHTz in their $6M Series B round (EV/Revenue multiple available to Pro users).
Latest Investments by Organo
| Description | LIGHTz is a San Francisco-based platform facilitating technology transfer and information exchange using AI-driven matchmaking. The service connects research institutions with industry partners by analyzing patents, publications, and market needs to identify licensing opportunities. LIGHTz supports universities like Stanford and companies in biotech and cleantech sectors through automated deal sourcing and collaboration tools. |
| HQ Country | |
| HQ City | Tsukuba |
| Deal Date | 18 Nov 2024 |
| Round | Series B |
| Raised | $6M |
| Investors | Shoko Chukin Bank; Organo; Tokyo Boeki Holdings |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Organo investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Organo
| When was Organo founded? | Organo was founded in 1941. |
| Where is Organo headquartered? | Organo is headquartered in Japan. |
| How many employees does Organo have? | As of today, Organo has over 2K employees. |
| Is Organo publicly listed? | Yes, Organo is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Organo? | Organo trades under 6368 ticker. |
| When did Organo go public? | Organo went public in 1961. |
| Who are competitors of Organo? | Organo main competitors include Fujian Funeng, Empower, Algonquin Power & Utilities, Global Power Synergy, China Resources Gas, NorthWestern Energy, TAQA Morocco, TAURON, China Power, Riyadh Cables. |
| What is the current market cap of Organo? | Organo's current market cap is $4.4B. |
| What is the current revenue of Organo? | Organo's last 12 months revenue is $1.2B. |
| What is the current revenue growth of Organo? | Organo revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Organo? | Current revenue multiple of Organo is 3.5x. |
| What is the current EBITDA of Organo? | Organo's last 12 months EBITDA is $258M. |
| What is Organo's EBITDA margin? | Organo's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Organo? | Current EBITDA multiple of Organo is 15.9x. |
| What is the current FCF of Organo? | Organo's last 12 months FCF is $95M. |
| What is Organo's FCF margin? | Organo's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of Organo? | Current FCF multiple of Organo is 43.1x. |
| How many companies Organo has acquired to date? | Organo hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Organo has invested to date? | As of July 2026, Organo has invested in 1 company. |
| What was the last Organo investment? | On 18th November 2024 Organo invested in LIGHTz, participating in a $6M Series B round, alongside Shoko Chukin Bank and Tokyo Boeki Holdings. |
| In what companies Organo invested in? | Organo invested in LIGHTz. |
See public comps similar to Organo
Lists including Organo
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.





